Address
1020 Stony Hill Road
Yardley, PA 19067
United States of America (the)
Phone
267 364 3500
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
127
First IPO Date
October 13, 2017
| Name | Title | Pay | Year Born |
| Ramy A. Mahmoud | Chief Executive Officer & Director | 1.44M | 1965 |
| Paul Spence | Chief Commercial Officer | 712,448 | 1969 |
| Michael F. Marino | Chief Legal Officer & Corporate Secretary | 781,539 | 1976 |
| Anthony Krick | Vice President of Finance & Chief Accounting Officer | 0 | 1981 |
| Jonathan Neely | Vice President of Investor Relations & Business Development | 0 | N/A |
| Karen E. Brophy | Chief Human Resources Officer & Vice President of Human Resources | 0 | 1963 |
| Terence Kohler | Chief Financial Officer | 0 | N/A |
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.